Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1057409 | 1.00 | CA2 (0.34) | CA2 | |
| SCHEMBL9794366 | 1.00 | CA2 (0.34) | CA2 | |
| SCHEMBL31682138 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL31682159 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL9794171 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL31682129 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL9794153 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL9794169 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL9794156 | 0.98 | CA2 (0.33) | CA2 | |
| SCHEMBL9794085 | 0.98 | CA2 (0.33) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1436252-A4 | HYDROXYFATTYSULFONIC ACID ANALOGS | TAISHO PHARMACEUTICAL CO LTD (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-20050020680-A1 | Hydroxyfattysulfonic acid analogs | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-01-27 | — | — | US | disclosed |
| EP-1436252-A1 | HYDROXYFATTYSULFONIC ACID ANALOGS | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003024922-A1 | HYDROXYFATTYSULFONIC ACID ANALOGS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020680-A1 | Hydroxyfattysulfonic acid analogs | ELANE, HRH2, APEH | CA2 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.